Jarrett R F, Mitsuya H, Mann D L, Cossman J, Broder S, Reitz M S
J Exp Med. 1986 Feb 1;163(2):383-99. doi: 10.1084/jem.163.2.383.
We studied the configuration and expression of the gene encoding the beta chain of the T cell receptor (TCR beta) in cell lines and primary tumor cells infected by the human T cell leukemia/lymphoma (lymphotrophic) virus type I (HTLV-I). Most of the cell lines and all the primary tumor cells showed rearrangement of the TCR beta gene, and in each case the rearrangement was distinct. The majority of cases examined were clonal with respect to a particular TCR beta gene rearrangement. Primary tumor cells from one case (SD) were found to have a tandem duplication of a portion of chromosome 7; this appears to have resulted in the presence of three alleles of the TCR beta gene, each of which is arranged differently. This suggests that the chromosomal abnormality, and possibly infection by HTLV-I, occurred before TCR beta gene rearrangement. Cell lines infected by HTLV-I express levels of TCR beta mRNA similar to PHA stimulated lymphocytes, suggesting that this gene is not transcriptionally activated as a result of infection by HTLV-I. Cloned T cells of known antigen specificity that are infected by HTLV-I in vitro show impairment of immune function, including loss of antigen-specific responsiveness and the acquisition of alloreactivity. Comparison of the configuration of the TCR beta gene before and after infection revealed no changes detectable by Southern blot analysis. Levels of expression of the TCR beta gene at the mRNA level and surface expression of the T3 complex were also not significantly altered, suggesting that changes in immune function cannot be attributed to quantitative changes in the TCR molecule. The configuration of the TCR beta gene in primary tumor cells infected by HTLV-I was compared with that in the derived cell lines. In all pairs examined, the configuration in the primary tumor cells was different from that in the cell lines, strongly suggesting that the cells that grow in culture are not the original neoplastic cells.
我们研究了人类T细胞白血病/淋巴瘤(嗜淋巴细胞)I型病毒(HTLV-I)感染的细胞系和原发性肿瘤细胞中编码T细胞受体β链(TCRβ)的基因的结构及表达情况。大多数细胞系和所有原发性肿瘤细胞均显示TCRβ基因重排,且每种情况下的重排都是独特的。在所检测的大多数病例中,就特定的TCRβ基因重排而言是克隆性的。发现一例(SD)原发性肿瘤细胞存在7号染色体部分区域的串联重复;这似乎导致了TCRβ基因三个等位基因的存在,每个等位基因的排列方式都不同。这表明染色体异常以及可能的HTLV-I感染发生在TCRβ基因重排之前。HTLV-I感染的细胞系表达的TCRβ mRNA水平与PHA刺激的淋巴细胞相似,这表明该基因不会因HTLV-I感染而转录激活。体外被HTLV-I感染的已知抗原特异性的克隆T细胞显示免疫功能受损,包括抗原特异性反应性丧失和同种异体反应性的获得。感染前后TCRβ基因结构的比较显示,Southern印迹分析未检测到变化。TCRβ基因在mRNA水平的表达量以及T3复合物的表面表达也未发生显著改变,这表明免疫功能的变化不能归因于TCR分子的定量变化。将HTLV-I感染的原发性肿瘤细胞中TCRβ基因的结构与衍生细胞系中的结构进行了比较。在所有检测的配对中,原发性肿瘤细胞中的结构与细胞系中的不同,强烈表明在培养中生长的细胞不是原始的肿瘤细胞。